{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:18:35Z","timestamp":1775931515996,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Alcon Japan Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00417-020-04925-z","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T07:03:28Z","timestamp":1600239808000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atopic dermatitis as a risk factor for severe visual field loss in youth\u2014a retrospective cohort study of glaucoma under steroid treatment"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-0898","authenticated-orcid":false,"given":"Kenji","family":"Suda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamichi","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanako Ohashi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"key":"4925_CR1","first-page":"187","volume":"4","author":"MF Armaly","year":"1965","unstructured":"Armaly MF (1965) Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Investig Ophthalmol 4:187\u2013197","journal-title":"Investig Ophthalmol"},{"key":"4925_CR2","first-page":"198","volume":"4","author":"B Becker","year":"1965","unstructured":"Becker B (1965) Intraocular pressure response to topical corticosteroids. Investig Ophthalmol 4:198\u2013205","journal-title":"Investig Ophthalmol"},{"key":"4925_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","volume":"11","author":"S Phulke","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S, Pandav SS (2017) Steroid-induced glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract 11:67\u201372. https:\/\/doi.org\/10.5005\/jp-journals-10028-1226","journal-title":"J Curr Glaucoma Pract"},{"key":"4925_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2016.06.018","volume":"787","author":"A Dibas","year":"2016","unstructured":"Dibas A, Yorio T (2016) Glucocorticoid therapy and ocular hypertension. Eur J Pharmacol 787:57\u201371. https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.018","journal-title":"Eur J Pharmacol"},{"key":"4925_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preteyeres.2016.09.003","volume":"56","author":"ME Fini","year":"2017","unstructured":"Fini ME, Schwartz SG, Gao X et al (2017) Steroid-induced ocular hypertension\/glaucoma: Focus on pharmacogenomics and implications for precision medicine. Prog Retin Eye Res 56:58\u201383. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.09.003","journal-title":"Prog Retin Eye Res"},{"key":"4925_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L et al (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma Clin Immunol 9:1. https:\/\/doi.org\/10.1186\/1710-1492-9-30","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"4925_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/1346-8138.14193","volume":"45","author":"YB Lee","year":"2018","unstructured":"Lee YB, Lee JH, Kang MJ et al (2018) Association between allergic diseases and ophthalmologic diseases, including cataracts and glaucoma, using the Korean National Health and Nutrition Examination Survey 2010\u20132012: A STROBE-compliant article. J Dermatol 45:463\u2013467. https:\/\/doi.org\/10.1111\/1346-8138.14193","journal-title":"J Dermatol"},{"key":"4925_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","volume":"141","author":"PW Sullivan","year":"2018","unstructured":"Sullivan PW, Ghushchyan VH, Globe G, Schatz M (2018) Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol 141:110\u2013116.e7. https:\/\/doi.org\/10.1016\/j.jaci.2017.04.009","journal-title":"J Allergy Clin Immunol"},{"key":"4925_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","volume":"277","author":"E Garbe","year":"1997","unstructured":"Garbe E, LeLorier J, Boivin JF, Suissa S (1997) Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. J Am Med Assoc 277:722\u2013727. https:\/\/doi.org\/10.1001\/jama.1997.03540330044033","journal-title":"J Am Med Assoc"},{"key":"4925_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.eye.6701895","volume":"20","author":"JP Kersey","year":"2006","unstructured":"Kersey JP, Broadway DC (2006) Corticosteroid-induced glaucoma: a review of the literature. Eye 20:407\u2013416. https:\/\/doi.org\/10.1038\/sj.eye.6701895","journal-title":"Eye"},{"key":"4925_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/archopht.1969.00990010790006","volume":"81","author":"RE Kalina","year":"1969","unstructured":"Kalina RE (1969) Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol 81:788\u2013790. https:\/\/doi.org\/10.1001\/archopht.1969.00990010790006","journal-title":"Arch Ophthalmol"},{"key":"4925_CR12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","volume":"74","author":"C Dejaco","year":"2015","unstructured":"Dejaco C, Singh YP, Perel P et al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799\u20131807. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207492","journal-title":"Ann Rheum Dis"},{"key":"4925_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1089\/thy.2013.0445","volume":"24","author":"N Curr\u00f2","year":"2014","unstructured":"Curr\u00f2 N, Covelli D, Vannucchi G et al (2014) Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy. Thyroid 24:897\u2013905. https:\/\/doi.org\/10.1089\/thy.2013.0445","journal-title":"Thyroid"},{"key":"4925_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG et al (2017) Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA - J Am Med Assoc 318:432\u2013442. https:\/\/doi.org\/10.1001\/jama.2017.9362","journal-title":"JAMA - J Am Med Assoc"},{"key":"4925_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.resinv.2018.03.003","volume":"56","author":"S Homma","year":"2018","unstructured":"Homma S, Bando M, Azuma A et al (2018) Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir Investig 56:268\u2013291. https:\/\/doi.org\/10.1016\/j.resinv.2018.03.003","journal-title":"Respir Investig"},{"key":"4925_CR16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492\u2013509. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204573","journal-title":"Ann Rheum Dis"},{"key":"4925_CR17","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.ophtha.2004.03.029","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase A, Suzuki Y, Araie M et al (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111:1641\u20131648. https:\/\/doi.org\/10.1016\/j.ophtha.2004.03.029","journal-title":"Ophthalmology"},{"key":"4925_CR18","doi-asserted-by":"publisher","unstructured":"Gordon MO, Torri V, Miglior S, et al (2007) Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114 https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.031","DOI":"10.1016\/j.ophtha.2006.08.031"},{"key":"4925_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/bjo.77.3.176","volume":"77","author":"JL Jay","year":"1993","unstructured":"Jay JL, Murdoch JR (1993) The rate of visual field loss in untreated primary open angle glaucoma. Br J Ophthalmol 77:176\u2013178. https:\/\/doi.org\/10.1136\/bjo.77.3.176","journal-title":"Br J Ophthalmol"},{"key":"4925_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IJG.0000000000000069","volume":"24","author":"K Takakuwa","year":"2015","unstructured":"Takakuwa K, Hamanaka T, Mori K et al (2015) Atopic glaucoma: clinical and pathophysiological analysis. J Glaucoma 24:662\u2013668. https:\/\/doi.org\/10.1097\/IJG.0000000000000069","journal-title":"J Glaucoma"},{"key":"4925_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.steroids.2011.02.003","volume":"76","author":"O Emin","year":"2011","unstructured":"Emin O, Fatih M, Mustafa O et al (2011) Evaluation impact of long-term usage of inhaled fluticasone propionate on ocular functions in children with asthma. Steroids 76:548\u2013552. https:\/\/doi.org\/10.1016\/j.steroids.2011.02.003","journal-title":"Steroids"},{"key":"4925_CR22","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C et al (2015) Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 373:2225\u20132236. https:\/\/doi.org\/10.1056\/NEJMoa1415463","journal-title":"N Engl J Med"},{"key":"4925_CR23","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1681\/ASN.2007020166","volume":"18","author":"V Jha","year":"2007","unstructured":"Jha V, Ganguli A, Saha TK et al (2007) A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 18:1899\u20131904. https:\/\/doi.org\/10.1681\/ASN.2007020166","journal-title":"J Am Soc Nephrol"},{"key":"4925_CR24","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","volume":"24","author":"N MacHardy","year":"2009","unstructured":"MacHardy N, Miles PV, Massengill SF et al (2009) Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 24:2193\u20132201. https:\/\/doi.org\/10.1007\/s00467-009-1282-y","journal-title":"Pediatr Nephrol"},{"key":"4925_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0002-9394(14)70883-9","volume":"124","author":"K Ohtsuka","year":"1997","unstructured":"Ohtsuka K (1997) Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy. Am J Ophthalmol 124:570\u2013572. https:\/\/doi.org\/10.1016\/S0002-9394(14)70883-9","journal-title":"Am J Ophthalmol"},{"key":"4925_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/eye.2008.155","volume":"23","author":"FLM Da Silva","year":"2009","unstructured":"Da Silva FLM, De Lourdes Veronese Rodrigues M, Akaishi PMS, Cruz AAV (2009) m Graves\u2019 orbitopathy: frequency of ocular hypertension and glaucoma. Eye 23:957\u2013959. https:\/\/doi.org\/10.1038\/eye.2008.155","journal-title":"Eye"},{"key":"4925_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/IJG.0b013e31816c4db3","volume":"17","author":"SE Skalicky","year":"2008","unstructured":"Skalicky SE, Borovik AM, Masselos K et al (2008) Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 17:249. https:\/\/doi.org\/10.1097\/IJG.0b013e31816c4db3","journal-title":"J Glaucoma"},{"key":"4925_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","volume":"72","author":"N Duru","year":"2013","unstructured":"Duru N, Van Der Goes MC, Jacobs JWG et al (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 72:1905\u20131913. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203249","journal-title":"Ann Rheum Dis"},{"key":"4925_CR29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10067-013-2214-6","volume":"32","author":"L Carli","year":"2013","unstructured":"Carli L, Tani C, Querci F et al (2013) Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists\u2019 practice for the monitoring of glucocorticoid eye toxicity. Clin Rheumatol 32:1071\u20131073. https:\/\/doi.org\/10.1007\/s10067-013-2214-6","journal-title":"Clin Rheumatol"},{"key":"4925_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/pde.13678","volume":"36","author":"LM LePoidevin","year":"2019","unstructured":"LePoidevin LM, Lee DE, Shi VY (2019) A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol 36:36\u201365. https:\/\/doi.org\/10.1111\/pde.13678","journal-title":"Pediatr Dermatol"},{"key":"4925_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaad.2010.01.035","volume":"64","author":"IM Haeck","year":"2011","unstructured":"Haeck IM, Rouwen TJ, Timmer-De Mik L et al (2011) Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. J Am Acad Dermatol 64:275\u2013281. https:\/\/doi.org\/10.1016\/j.jaad.2010.01.035","journal-title":"J Am Acad Dermatol"},{"key":"4925_CR32","doi-asserted-by":"publisher","unstructured":"Tamagawa-Mineoka R, Yasuoka N, Ueta M, Katoh N (2018) Influence of topical steroids on intraocular pressure in patients with atopic dermatitis. Allergol Int 10\u201313. https:\/\/doi.org\/10.1016\/j.alit.2018.01.004","DOI":"10.1016\/j.alit.2018.01.004"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-04925-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-04925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T23:50:46Z","timestamp":1631749846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-04925-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4925"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-04925-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"16 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/Consent to publish"}},{"value":"All research and measurements adhered to the tenets of the Declaration of Helsinki after the approval of the Kyoto University Graduate School and Faculty of Medicine Ethics Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not commissioned; externally peer reviewed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Provenance and peer review"}}]}}